FGF23 and heart rhythm in dialysis patients
Part of Heart & circulation clinical trials.
This study looks at whether a blood protein called FGF23 is linked to irregular heartbeats in people on long-term hemodialysis (kidney dialysis). It may help doctors better predict heart risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can give your consent to participate
- You have been on maintenance hemodialysis for at least 3 months
- You do not have a history of atrial fibrillation (a type of irregular heartbeat) or a pacemaker
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at heart and bone health in people on dialysis compared to healthy volunteers. If you are on dialysis for at least 6 months, or if you are healthy with no kidney issues, you may be able to join.
This study looks at how the heart and blood vessels work together during dialysis. It may help doctors understand why some patients have heart problems during treatment.
This study looks at changes in a heart rhythm measurement called QTc interval in people on regular dialysis. It may help doctors understand heart risks in dialysis patients.
This study looks at how high potassium levels (hyperkalemia) in people with chronic kidney disease may affect the heart. Doctors will use echocardiograms (heart ultrasounds) to check for changes.
This study looks at a blood hormone called FGF23 and whether it is linked to heart (cardiovascular) problems in people with anemia. It also compares people with anemia who do and do not have chronic kidney disease, which may help researchers understand risk and targets.
This study looks at a substance in your blood called FGF23 that can rise as kidney disease gets worse. Researchers want to see how the level of this substance changes at different stages of CKD.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.